This grant is for the Human Tissue Core, integral to the Molecular Atlas of Lung Development (LungMAP) program. The primary purpose of LungMAP is to construct a comprehensive molecular and cellular atlas of the human lung. This atlas will serve as a vital reference platform to enhance understanding of normal lung biology and disease pathobiology. It aims to pinpoint crucial cellular components, molecular pathways, and novel therapeutic targets relevant to lung diseases. LungMAP is designed as an open-access resource, meticulously integrating multi-scale, high-content, and high-resolution data to define lung cells based on gene expression, physiological states, 3-dimensional locations, and their developmental and pathological trajectories.
Opportunity ID: 349294
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-24-012 |
| Funding Opportunity Title: | Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Human Tissue Core (U01- Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.838 — Lung Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 14, 2023 |
| Last Updated Date: | Sep 06, 2023 |
| Original Closing Date for Applications: | Oct 27, 2023 |
| Current Closing Date for Applications: | Sep 06, 2023 |
| Archive Date: | Oct 06, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following:See full Notice of Funding Opportunity for additional information on eligibility. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The objective of the Molecular Atlas of Lung Development (LungMAP) program is to build a comprehensive molecular and cellular atlas of the human lung to serve as a reference platform to better understand both normal biology and disease pathobiology, and to identify critical cellular components, molecular pathways, and novel therapeutic targets in lung disease. LungMAP is an open access resource integrating multi-scale, high-content, high-resolution information to define lung cells with gene expression, physiological states, 3-dimensional locations, as well as developmental and pathological trajectories. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-24-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Closing per issuance of RFA-HL-24-015 | Sep 06, 2023 | |
| Jul 14, 2023 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-24-012 |
| Funding Opportunity Title: | Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Human Tissue Core (U01- Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.838 — Lung Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 14, 2023 |
| Last Updated Date: | Sep 06, 2023 |
| Original Closing Date for Applications: | Oct 27, 2023 |
| Current Closing Date for Applications: | Sep 06, 2023 |
| Archive Date: | Oct 06, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following:See full Notice of Funding Opportunity for additional information on eligibility. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The objective of the Molecular Atlas of Lung Development (LungMAP) program is to build a comprehensive molecular and cellular atlas of the human lung to serve as a reference platform to better understand both normal biology and disease pathobiology, and to identify critical cellular components, molecular pathways, and novel therapeutic targets in lung disease. LungMAP is an open access resource integrating multi-scale, high-content, high-resolution information to define lung cells with gene expression, physiological states, 3-dimensional locations, as well as developmental and pathological trajectories. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-24-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-HL-24-012 |
| Funding Opportunity Title: | Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 – Human Tissue Core (U01- Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.838 — Lung Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 14, 2023 |
| Last Updated Date: | Jul 14, 2023 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Oct 27, 2023 |
| Archive Date: | Dec 02, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: See full Notice of Funding Opportunity for additional information on eligibility. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The objective of the Molecular Atlas of Lung Development (LungMAP) program is to build a comprehensive molecular and cellular atlas of the human lung to serve as a reference platform to better understand both normal biology and disease pathobiology, and to identify critical cellular components, molecular pathways, and novel therapeutic targets in lung disease. LungMAP is an open access resource integrating multi-scale, high-content, high-resolution information to define lung cells with gene expression, physiological states, 3-dimensional locations, as well as developmental and pathological trajectories. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-24-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Related Documents
Folder 349294 Full Announcement-RFA-HL-24-012 -> RFA-HL-24-012-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00282566 | Sep 07, 2023 | Sep 07, 2023 | View |
Package 1
Mandatory forms
349294 RR_SF424_5_0-5.0.pdf
349294 PHS398_CoverPageSupplement_5_0-5.0.pdf
349294 RR_OtherProjectInfo_1_4-1.4.pdf
349294 PerformanceSite_4_0-4.0.pdf
349294 RR_KeyPersonExpanded_4_0-4.0.pdf
349294 PHS398_ResearchPlan_5_0-5.0.pdf
349294 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
349294 RR_Budget_3_0-3.0.pdf
349294 RR_SubawardBudget30_3_0-3.0.pdf
349294 PHS398_ModularBudget_1_2-1.2.pdf
349294 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
